Hence, our results might support a potential involvement of this myokine in glucose homeostasis and suggest that METRNL could be a potential predictive biomarker of insulin sensitivity and metabolic flexibility in postmenopausal women with overweight/obesity. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.